It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Bacteria have evolved a broad range of systems that provide defence against their viral predators, bacteriophages. Bacteriophage Exclusion (BREX) systems recognise and methylate 6 bp non-palindromic motifs within the host genome, and prevent replication of non-methylated phage DNA that encodes these same motifs. How BREX recognises cognate motifs has not been fully understood. In this study we characterise BREX from pathogenic Salmonella and present X-ray crystallographic structures of the conserved BREX protein, PglX. The PglX N-terminal domain encodes the methyltransferase, whereas the C-terminal domain is for motif recognition. We also present the structure of PglX bound to the phage-derived DNA mimic, Ocr, an inhibitor of BREX activity. Our analyses propose modes for DNA-binding by PglX and indicate that both methyltransferase activity and defence require larger BREX complexes. Through rational engineering of PglX we broaden both the range of phages targeted, and the host motif sequences that are methylated by BREX. Our data demonstrate that PglX is used to recognise specific DNA sequences for BREX activity, contributing to motif recognition for both phage defence and host methylation.
This study provides a structural and functional characterisation of the phage resistance system, BREX. Went et. al. provide structures of the methyltransferase component, PglX, and rationally mutate PglX to retarget BREX defence against new phages.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 South Road, Department of Biosciences, Durham University, Durham, UK (GRID:grid.8250.f) (ISNI:0000 0000 8700 0572)
2 New England Biolabs, Ipswich, USA (GRID:grid.273406.4) (ISNI:0000 0004 0376 1796)
3 Northumbria University, Faculty of Health and Life Sciences, Newcastle Upon Tyne, UK (GRID:grid.42629.3b) (ISNI:0000 0001 2196 5555)
4 University of Liverpool, Institute of Infection, Veterinary and Ecological Sciences, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470)
5 University of Surrey, Department of Microbial Sciences, Faculty of Health and Medical Sciences, Guildford, UK (GRID:grid.5475.3) (ISNI:0000 0004 0407 4824)